Record overview
Status and phase
Status: RECRUITING
Phase: PHASE2
Sponsor: University of Utah
Condition: Relapsed or Refractory Large B-cell Lymphoma
NCT06788964
Loncastuximab Tesirine and Rituximab as Bridging Therapy Before Standard-of-care CAR-T Therapy in Patients With Large B-cell Lymphoma (CORAL)
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: None
Results signal: Low Signal
Operational burden: strict_eligibility_signal | complex_intervention_signal
Stopped reason
Context when available
No stop reason available in the current public record.